Language
English
10
Average: 10 (1 vote)
Early Data Proves Pfizer Vaccines Don’t Prevent Transmission Needs Context
CONTEXT: PFIZER's EUA Data Submitted on Nov 20, 2020 Proves the PFIZER Vaccines cause Disease, Disabilities, Death, including COVID-19.
Oct 27, 2022
129
I agree with REUTERS, the Associated Press, and the fact-checking crews that claim the November 20, 2020, emergency use authorization (EUA) data submitted by PFIZER to the FDA ‘proves the EUA PFIZER vaccines didn’t prevent transmission’ needs context.
Here’s the context. The November 20, 2020 EUA PFIZER/BioNTech data submitted to the FDA irrefutably proves there is NO EVIDENCE that PFIZER mRNA vaccines prevent transmission. The data also proves that the PFIZER mRNA vaccines cause COVID-19.
This is the November 20, 2020, EUA data submission from PFIZER/BioNTech to the FDA.
Below is the primary endpoint efficacy data. The primary efficacy endpoint was the incidence of SARS-CoV-2 infection in patients from 1- week after their 2nd dose of PFIZER (or placebo), confirmed by reporting of COVID-19 symptoms AND a positive PCR-test.
According to the CDC (and the MAYO Clinic), patients are not ‘fully vaccinated’ until 2-weeks after their second dose of an mRNA COVID-19 vaccine, including PFIZER’s vaccine. Yet, the primary efficacy endpoint in the PFIZER study was a positive PCR test at 1-week post 2nd dose.
“Why is the primary efficacy endpoint for the PFIZER COVID-19 vaccine defined at a timepoint (1-week post 2nd dose) beginning before the mRNA COVID-19 vaccines are considered to be effective by the CDC (2-weeks post 2nd dose)? This makes no sense.” - Karen Kingston
The American people were told that PFIZER’s vaccine was 95% effective. That’s a blatant lie. The 95% percentage is the confidence interval. The CI next to the 95% stands for Confidence Interval.
Subscribe
The ‘real efficacy’ of the PFIZER vaccine was 99% effective from one-week post-2nd dose up to 2 months. If you received two (2) doses of the PFIZER vaccine you had a 99% chance of NOT getting infected with COVID-19 up to 1-week post 2nd dose up to 2 months.*
- *This is truly a miraculous efficacy endpoint for the vaccine study because PFIZER was able to prove that their vaccines were effective in preventing SARS-CoV-2 infection before the mRNA vaccines even had a chance to start working to prevent SARS-CoV-2 infection - according to the CDC’s definition of being ‘fully vaccinated’.
If we were to apply the study data to real world outcomes, this would mean that if you received two (2) doses of placebo (aka if you did nothing at all) you’d also have a 99% chance or greater of NOT getting infected with SARs-CoV-2 from one-week post- second dose up to 2 months of doing nothing versus getting injected with an experimental gene-editing mRNA technology.
There was NO EVIDENCE at all submitted to the FDA that proves the PFIZER vaccine had ANY EFFICACY IN PREVENTING SARs-CoV-2 transmission (but with a 95% confidence interval). In other words, you can be 95% confident that if you got 2 shots of PFIZER versus doing nothing at all, you would have a 99% chance of not getting COVID-19 within 7 -days of getting the PFIZER shot (because COVID-19 isn’t caused by the SARS-CoV-2 virus).
The fact that there was NO EVIDENCE at all submitted to the FDA proving the PFIZER vaccine had ANY EFFICACY IN PREVENTING SARs-CoV-2 transmission is confirmed by the FDA’s August 23, 2021 approval of Pfizer’s Biological License Application (BLA), which clearly states; MISSING INFORMATION = VACCINE EFFICACY.
Now let’s dive into the surprising data that proves the PFIZER vaccines cause COVID-19. Page 41 of PFIZER’s EUA submission, states that there were 409 patients who had COVID-19 symptoms within 7 days of getting their first (1st) or second (2nd) PFIZER shot, BUT these patients did not have a positive PCR-test for SARS-CoV-2 (because COVID-19 isn’t caused by the SARS-CoV-2 virus).
Per PFIZER’s own document, “unconfirmed COVID-19 cases could have masked clinically significant adverse events that would have otherwise been detected.”
Share The Kingston Report
Per PFIZER’s EUA submission, clinically significant or severe COVID-19 cases was defined in the Phase 3 Study as kidney, liver, or neurological dysfunction*, admission to the intensive care unit (ICU), or death.
*Question: How does a respiratory virus cause neurological dysfunction? I can see how a neuroweapon could cause neurological dysfunction, but a respiratory virus?
- The link inside this HHS document to the above the guidance chart has now been taken down by the FDA.
Under standard FDA law, the reporting of adverse events is mandatory in Phase 1/2/3 clinical trials.
CONUNDRUM: The conundrum for PFIZER is that PFIZER did go through the complete FDA approval process, from IND to FDA approval, and PFIZER’s EUA shield is now broken. Let’s walk through the basic steps.
Step 1: PFIZER submitted an initial new drug (IND) application.
Step 2: PFIZER submitted a biological license application (BLA) and paid the pharmaceutical drug user fee (PDUFA).
Step 3: PFIZER received FDA approval on August 23, 2021.
Step 4: PFIZER is marketing, distributing, and selling FDA-approved COMIRNATY in the United States.
PFIZER’s November 20, 2020, EUA data isn’t even EUA data. The November 20th data is interim IND Phase 3 data submitted under an EUA. PFIZER’s phase 1/2/3 trials (filed under an IND) are not and never were protected under the EUA laws, despite what we’ve been told.
According HHS Guidance on Withdrawal of Subjects from Research, under EUA research; reporting and record keeping of patients who withdraw from a study due to adverse events (including death), is NOT REQUIRED and up to the manufacturer (PFIZER/BioNTech).
It’s important to note that PFIZER listed adverse events and DEATH as reasons for WITHDRAWAL from their Phase 3 study design in their IND.
Under the illusion of EUA law, PFIZER has no responsibility to keep a record of adverse events or death. In other words, if a patient failed to show up for a study visit because they were hospitalized or died, PFIZER could just remove the patient’s file from the study with no record of what happened to that patient.
Share The Kingston Report
Per page 18, Table 2, of the November 20, 2020, submission, 622 PFIZER subjects were excluded (withdraw) for protocol deviations (vs 121 who were excluded/withdrew from the placebo group).
What were the reasons for the PFIZER subjects exclusion/withdrawal? Were they hospitalized? Did they die?
- It is evident that PFIZER and the FDA are in criminal violation of dozens of laws under the FDA&C Act. You can read some select violations of those laws here.
PFIZER and the FDA had evidence before PFIZER submitted Phase 3 data, that that the CLINICAL OUTCOMES of the COVID-19 vaccines included disease, disabilities, and death in adults and children.
In the phase 3 trial for adults, PFIZER had early evidence that the COVID-19 mRNA vaccines harmed and injured children. Per pages 15-16 of their Phase 3 data EUA submission, PFIZER states, “a total of 100 adolescents 12 through 15 years of age enrolled in Phase 2/3….the Sponsor (PFIZER) did not request inclusion of this age group in the EUA because the available data…were insufficient to support a favorable benefit-risk determination at this time.”
“100 adolescents 12 through 15 years of age enrolled in Phase 2/3….the Sponsor (PFIZER) did not request inclusion of this age group in the EUA because the available data…were insufficient to support a favorable benefit-risk determination at this time.” - PFIZER
Share The Kingston Report
PFIZER’s early phase 3 data for children aged 12-15 was damning. Maddie de Garay and thousands of other children never should have been subjected to PFIZER’s bioweapon injections resulting in these children becoming permanently disabled.
Per PFIZER’s own November 20, 2020, FDA document, PFIZER knew their mRNA injections would cause disease, disabilities and death. Ernie Ramirez’s son and thousands of other children should never have been murdered by PFIZER’s mRNA bioweapon injections.
PFIZER and the FDA are and were aware that it is statistically and clinically impossible to develop a vaccine for COVID-19 that would be more effective than a child’s natural immune system.
Per PFIZER’s June 10, 2021 FDA submission regarding their pediatric data and trials, PFIZER states, “…an adequately powered clinical endpoint efficacy trial…..may be very difficult, if not infeasible, to conduct..”
PFIZER’s mRNA COVID-19 vaccines cause COVID-19. PFIZER’s post-hoc analysis submitted to the FDA on September 17, 2021, states, “…the incidence of COVID-19 generally increased in each group of study participants with increasing time post-Dose 2.”. This means that two (2) doses of the PFIZER mRNA COVID-19 vaccine cause COVID-19.
“…the incidence of COVID-19 generally increased in each group of study participants with increasing time post-Dose 2.” - PFIZER
The adverse events of the COVID-19 mRNA vaccines are the same as the symptoms of COVID-19; resulting in disabilities, disease, and death.
The PFIZER COVID-19 vaccines are not vaccines. They are Ai bioweapons that can only cause disabling injuries, diseases and death.